Ram Babu Vedantham’s Post

The country’s drugs and pharmaceuticals exports increased 9.67 per cent year-on-year to USD 27.9 billion in 2023-24, even as the total exports dipped by 3 per cent in the last fiscal. According to the commerce ministry data, pharma exports in March grew by 12.73 per cent to USD 2.8 billion. Ministry of Commerce and Industry, Government of India To Read More: https://lnkd.in/dtkwW2Cw #pharamaceutical #pharma #export #shipping #supplychain #logistics #ecommerce #shipment

May pharma exports climb 10.5% to $2.3 bn India’s pharmaceutical exports rose 10.5% year-on-year to $2,301.88 million last month. “It is moving in a positive way and we are optimistic of sustaining growth of not less than 10%,” Pharmaceuticals Export Promotion Council of India DG Ravi Uday Bhaskar said on the Centre’s quick estimates released last week. For the first two months of FY25, the exports rose 8.85% to $4,730.66 million. On the fallout of geo-political crises, he said there were no disturbances in U.S., Europe and Africa markets that could have a bearing. The Russia-Ukraine war did make a little dent in the shipments, but the impact of Russia’s emphasis on localisation was bound to impact more.

India's pharma Exports Increase 10% to USD 27.9 Billion in FY24 The nation's drug and pharmaceutical exports rose 9.67 percent year-on-year to USD 27.9 billion in 2023-24, even though total exports decreased by 3% in the previous fiscal year. News: https://goo.su/c1Ret #pharmaceuticalexports #outboundshipments #exportmarkets #pharmaceuticalindustry #overseasmarkets

Currently, Russia imports a wide range of pharmaceutical goods from India, including generic drugs, active pharmaceutical ingredients (APIs), vaccines, and medical devices. Indian companies have established themselves as reliable suppliers, meeting the demand for essential medicines in the Russian market. What will be the dynamics of this sector in the coming year of 2025? Read in our new blog post ⤵️ #partner #businesspartner #partnerinrussia #businesswithrussia #russiaandindia #russianindiantrade #exportmarketing #marketing #newmarket #russianmarket #cismarket #export #exim #trade #CONSULTANT #service #import #exporters #exportimport #importexport #pharma #indianpharma

India's pharma exports rise 10% to $27.9 bn in FY24 💊 🏥 ⚕ In the fiscal year 2023-24, India's pharmaceutical exports surged by 9.67%, reaching USD 27.9 billion, showcasing robust growth despite a 3% dip in total exports. March alone witnessed a noteworthy 12.73% increase, totaling USD 2.8 billion, as per commerce ministry data. This momentum builds upon the previous fiscal's export figures of USD 25.4 billion. The sector's top export markets include the US, the UK, the Netherlands, South Africa, and Brazil, with the US alone constituting over 31% of India's pharma exports, followed by the UK and the Netherlands, each around 3%. Notably, India's pharmaceutical exports expanded into new territories such as Montenegro, South Sudan, Comoros, and Brunei, signaling the industry's increasing global footprint. With experts foreseeing India's pharmaceutical business to potentially surpass $130 billion by 2030, driven by burgeoning market opportunities and heightened overseas demand, the industry's current worth of over $50 billion in 2022-23 may just be the beginning. Monthly, India consistently exports pharmaceutical products worth USD 2-3 billion, highlighting its sustained contribution to the global healthcare market. As the third-largest pharmaceutical industry by volume and 13th largest by value globally, India produces an extensive range of over 60,000 generic drugs across 60 therapeutic categories. To bolster domestic manufacturing, the government has introduced two production-linked incentive (PLI) schemes targeting key pharmaceutical ingredients and generic medicines. These initiatives underscore India's commitment to not only meet domestic demand but also solidify its position as a pharmaceutical powerhouse on the global stage. #pharmamanufacturing #pharmaindustry #sunpharma #glenmarkpharma #cipla #pharmaceuticalsales #customsynthesis

Pharmaceutical exports on track for accelerated growth Day #71 of covering Pharma Developments. 💊News Buzz.. Indian Pharma exports to grow at around 11% and reach $31 billion in FY25. 💊Where are we exporting to.? More than 50% of exports last year were to highly regulated markets like North America and Europe. 💊Major surge of exports Even when there were a lot of challenges pharmaceutical exports to the U.S. increased 15% to more than $8 billion, while the exports to the U.K. were 21% higher at $783 million. 💊What was our growth rate in FY24.? We grew by 10% in FY24 to hit $27.8 billion. I will provide the source of the article in the comment section below. By the way today is the 71st day of me deep diving into the pharmaceutical industry. I will be sharing insights from this industry on a regular basis. So please do follow me (Krishna Raj K) for such insights. #finance #Linkedin #India

India's pharma exports to the US have surged 15% in the first 11 months of the last financial year despite regulatory challenges and rising pricing pressures. The pace of exports has more than doubled from the 6.18% growth in the same period of FY23, according to estimates by Pharmaceutical Export Promotion Council (Pharmexcil). Exports to the US climbed to $7.83 billion during the April-February period from $6.8 billion in the same period in FY23. Stay tuned for more updates and photos from this exciting venture on our LinkedIn page! #export #Innovation #dailyupdate #pharmaceuticalindustry

India’s #pharmaceutical exports have shown remarkable #growth in the first quarter of 2024. Here are the key highlights: Exports to the US: Despite lane wise #regulatory challenges and rising pricing pressures, India’s pharma exports to the US surged by 15% in the first 11 months of the last financial year (FY24). The pace of exports more than doubled compared to the same period in FY23, which had seen a growth rate of only 6.18%. Exports to the US reached $7.83 billion during the April-February period, up from $6.8 billion in the same period in FY23. The US contributes approximately 30% of India’s total pharmaceutical exports. Overall Pharmaceutical Exports: India’s total pharmaceutical exports increased by 9.34% during the same period, reaching $25.04 billion from $22.9 billion in the previous year. This growth in exports is positive news for the Indian #pharmaindustry, especially after experiencing negative growth in 2022. The industry has faced challenges, but the recent surge in US #exports indicates a promising trend. #Pharmagrowth #India #Indiagrowthstory

#Pharma Sector India’s pharmaceuticals exports rise 10% to $28 billion in FY24 On average, India exports pharma products worth USD 2-3 billion every month. India’s pharmaceutical industry is the third largest by volume and the 13th largest by value in the world, producing more than 60,000 generic drugs across 60 therapeutic categories. The government has rolled out two production-linked incentive (PLI) schemes to promote domestic manufacturing of key pharmaceutical ingredients and generic medicines. We have seen recent approvals and better USFDA reports on Indian pharma sector. Technical charts have become positive and buy signals are appearing. CAPEX have been completing and production capacities are coming on line. We can focus on export oriented companies in NIFTY PHARMA. Same is getting true for CHEMICALS. Leaders like Sudarshan Chemicals, EPIGRAL, Archean Chemicals have shown bottoms. It seems worst is over there. More clarity will appear on demand, late this year. https://lnkd.in/dtZGTQad

Pakistan's pharmaceutical exports have shown impressive growth, registering a 31.11% rise in the first quarter of the financial year 2024-25 compared to the same period last year. Between July and September 2024, exports in this sector reached $105.936 million, a notable increase from $80.796 million during these months in 2023, according to data from the Pakistan Bureau of Statistics (PBS). In September 2024, the pharmaceutical industry saw an even more remarkable year-on-year surge of 61.55%, with export values reaching $43.607 million, up from $26.992 million in September 2023. The sector also demonstrated strong monthly growth, recording a 53.78% increase from $28.357 million in August 2024. This upward trend highlights the growing capabilities and global competitiveness of Pakistan's pharmaceutical sector. With these advancements, the industry is solidifying its place in the international market, furthering the recognition of Pakistani products worldwide. #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation